Page last updated: 2024-08-21
medroxyprogesterone and Benign Cerebellar Neoplasms
medroxyprogesterone has been researched along with Benign Cerebellar Neoplasms in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Altinoz, MA; Del Maestro, RF; Elmaci, I; Emin Ozcan, M; Nalbantoglu, J; Ozpinar, A | 1 |
Other Studies
1 other study(ies) available for medroxyprogesterone and Benign Cerebellar Neoplasms
Article | Year |
---|---|
From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.
Topics: Animals; Brain; Brain Neoplasms; Cerebellar Neoplasms; Dexamethasone; Disease Models, Animal; Glioblastoma; Glioma; Humans; Medroxyprogesterone; Meningioma; Rats; Tumor Cells, Cultured | 2018 |